Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Diacylglycerol kinase (DGK) plays an important role in signal transduction through modulating the balance between two signaling lipids, diacylglycerol and phosphatidic acid. In yeast two-hybrid screening, we unexpectedly found a self-association of the C-terminal part of
DGKdelta
containing a sterile alpha-motif (SAM) domain. We then bacterially expressed the SAM domain fused with maltose-binding protein and confirmed the formation of dimeric and tetrameric structures. Moreover, gel filtration and co-immunoprecipitation analyses demonstrated that
DGKdelta
formed homo-oligomeric structures in intact cells and that the SAM domain was critically involved in the oligomerization. Interestingly, phorbol ester stimulation induced dissociation of the oligomeric structures with concomitant phosphorylation of
DGKdelta
. Furthermore, we found that
DGKdelta
was translocated from cytoplasmic vesicles to the plasma membrane upon phorbol ester stimulation. In this case,
DGKdelta
mutants lacking the ability of self-association were localized at the plasma membranes even in the absence of phorbol ester. A protein kinase C inhibitor, staurosporine, blocked all of the effects of phorbol ester, i.e. oligomer dissociation, phosphorylation, and translocation. We confirmed that tumor-promoting phorbol esters did not directly bind to
DGKdelta
. The present studies demonstrated that the formation and dissociation of oligomers serve as the regulatory mechanisms of
DGKdelta
and that
DGKdelta
is a novel downstream effector of phorbol ester/
protein kinase C
signaling pathway.
...
PMID:Phorbol ester-regulated oligomerization of diacylglycerol kinase delta linked to its phosphorylation and translocation. 1208 10
Diacylglycerol kinases (DGKs) phosphorylate diacylglycerol (DAG) to terminate its signaling. To study
DGKdelta
, we disrupted its gene in mice and found that
DGKdelta
deficiency reduced EGF receptor (EGFR) protein expression and activity. Similar to EGFR knockout mice,
DGKdelta
-deficient pups were born with open eyelids and died shortly after birth. PKCs are activated by DAG and phosphorylate EGFR to reduce its expression and activity. We found DAG accumulation, increased threonine phosphorylation of EGFR, enhanced phosphorylation of other
PKC
substrates, and increased
PKC
autophosphorylation in
DGKdelta
knockout cells, indicating that
DGKdelta
regulates EGFR by modulating
PKC
signaling.
...
PMID:Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling. 1702 Oct 16
Although chronic hyperglycemia reduces insulin sensitivity and leads to impaired glucose utilization, short term exposure to high glucose causes cellular responses positively regulating its own metabolism. We show that exposure of L6 myotubes overexpressing human insulin receptors to 25 mm glucose for 5 min decreased the intracellular levels of diacylglycerol (DAG). This was paralleled by transient activation of diacylglycerol kinase (DGK) and of insulin receptor signaling. Following 30-min exposure, however, both DAG levels and DGK activity returned close to basal levels. Moreover, the acute effect of glucose on DAG removal was inhibited by >85% by the DGK inhibitor R59949. DGK inhibition was also accompanied by increased
protein kinase C
-alpha (PKCalpha) activity, reduced glucose-induced insulin receptor activation, and GLUT4 translocation. Glucose exposure transiently redistributed DGK isoforms alpha and delta, from the prevalent cytosolic localization to the plasma membrane fraction. However, antisense silencing of
DGKdelta
, but not of DGKalpha expression, was sufficient to prevent the effect of high glucose on PKCalpha activity, insulin receptor signaling, and glucose uptake. Thus, the short term exposure of skeletal muscle cells to glucose causes a rapid induction of DGK, followed by a reduction of PKCalpha activity and transactivation of the insulin receptor signaling. The latter may mediate, at least in part, glucose induction of its own metabolism.
...
PMID:Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol kinase subcellular localization. 1767 99
The delta-isozyme (type II) of diacylglycerol kinase (DGK) is known to positively regulate growth factor receptor signaling.
DGKdelta
, which is distributed to clathrin-coated vesicles, interacts with
DGKdelta
itself,
protein kinase C
and AP2alpha. To search for additional
DGKdelta
-interacting proteins, we screened a yeast two-hybrid cDNA library from HepG2 cells using aa 896-1097 of
DGKdelta
as a bait. We identified aa 184-317 (WD40 repeats 5-7) of receptor for activated C kinase 1 (RACK1), which interacts with various important signaling molecules, as a novel binding partner of
DGKdelta
. Co-immunoprecipitation analysis, using COS-7 cells co-expressing RACK1 and
DGKdelta
, revealed that RACK1 selectively interacted with
DGKdelta
, but not with type I DGKs, in mammalian cells. The interaction was dynamically regulated by phorbol ester. Intriguingly,
DGKdelta
appeared to recruit RACK1 to clathrin-coated vesicles and co-localized with RACK1. These results suggest that
DGKdelta
serves as an adaptor protein to regulate the localization of the versatile scaffold protein, RACK1.
...
PMID:Diacylglycerol kinase delta associates with receptor for activated C kinase 1, RACK1. 1941 40